Selected research
Industry Research
Molecular Diagnostic Reagent Industry Research Report 2026
Market perspective
The global Molecular Diagnostic Reagent market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Molecular Diagnostic Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Molecular Diagnostic Reagent is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Molecular Diagnostic Reagent is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Molecular Diagnostic Reagent include Abbott Laboratories, Thermo Fisher Scientific, Merck KGaA, Roche Diagnostics, Siemens AG, Qiagen, Illumina, Hologic and Grifols, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Molecular Diagnostic Reagent market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Molecular Diagnostic Reagent Market by Company
Abbott Laboratories
Thermo Fisher Scientific
Merck KGaA
Roche Diagnostics
Siemens AG
Qiagen
Illumina
Hologic
Grifols
Diasorin
Danaher Corporation
DaAn Gene
Bio-Rad Laboratories
Biomérieux Sa
Becton, Dickinson and Company
Agilent Technologies
Molecular Diagnostic Reagent Segment by Type
Polymerase Chain Reaction PCR
Gene chip
Gene Sequencing
Molecular Hybridization
Molecular Diagnostic Reagent Segment by Application
Infectious Disease Diagnosis
Genetic Diagnosis
Blood Screening
Other
Molecular Diagnostic Reagent Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molecular Diagnostic Reagent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Molecular Diagnostic Reagent and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molecular Diagnostic Reagent.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Molecular Diagnostic Reagent manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Molecular Diagnostic Reagent by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Molecular Diagnostic Reagent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Polymerase Chain Reaction PCR
- Gene chip
- Gene Sequencing
- Molecular Hybridization
Applications
- Infectious Disease Diagnosis
- Genetic Diagnosis
- Blood Screening
- Other
Companies covered
- Abbott Laboratories
- Thermo Fisher Scientific
- Merck KGaA
- Roche Diagnostics
- Siemens AG
- Qiagen
- Illumina
- Hologic
- Grifols
- Diasorin
- Danaher Corporation
- DaAn Gene
- Bio-Rad Laboratories
- Biomérieux Sa
- Becton, Dickinson and Company
- Agilent Technologies
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Molecular Diagnostic Reagent Market Size (2021-2032)
- 2.2.2 Global Molecular Diagnostic Reagent Sales (2021-2032)
- 2.2.3 Global Molecular Diagnostic Reagent Market Average Price (2021-2032)
- 2.3 Molecular Diagnostic Reagent by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Polymerase Chain Reaction PCR
- 2.3.3 Gene chip
- 2.3.4 Gene Sequencing
- 2.3.5 Molecular Hybridization
- 2.4 Molecular Diagnostic Reagent by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Infectious Disease Diagnosis
- 2.4.3 Genetic Diagnosis
- 2.4.4 Blood Screening
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Molecular Diagnostic Reagent Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Molecular Diagnostic Reagent Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Molecular Diagnostic Reagent Revenue of Manufacturers (2021-2026)
- 3.4 Global Molecular Diagnostic Reagent Average Price by Manufacturers (2021-2026)
- 3.5 Global Molecular Diagnostic Reagent Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Molecular Diagnostic Reagent, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Molecular Diagnostic Reagent, Product Type & Application
- 3.8 Global Manufacturers of Molecular Diagnostic Reagent, Established Date
- 3.9 Global Molecular Diagnostic Reagent Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbott Laboratories
- 4.1.1 Abbott Laboratories Company Information
- 4.1.2 Abbott Laboratories Business Overview
- 4.1.3 Abbott Laboratories Molecular Diagnostic Reagent Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Abbott Laboratories Molecular Diagnostic Reagent Product Portfolio
- 4.1.5 Abbott Laboratories Recent Developments
- 4.2 Thermo Fisher Scientific
- 4.2.1 Thermo Fisher Scientific Company Information
- 4.2.2 Thermo Fisher Scientific Business Overview
- 4.2.3 Thermo Fisher Scientific Molecular Diagnostic Reagent Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Thermo Fisher Scientific Molecular Diagnostic Reagent Product Portfolio
- 4.2.5 Thermo Fisher Scientific Recent Developments
- 4.3 Merck KGaA
- 4.3.1 Merck KGaA Company Information
- 4.3.2 Merck KGaA Business Overview
- 4.3.3 Merck KGaA Molecular Diagnostic Reagent Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merck KGaA Molecular Diagnostic Reagent Product Portfolio
- 4.3.5 Merck KGaA Recent Developments
- 4.4 Roche Diagnostics
- 4.4.1 Roche Diagnostics Company Information
- 4.4.2 Roche Diagnostics Business Overview
- 4.4.3 Roche Diagnostics Molecular Diagnostic Reagent Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Roche Diagnostics Molecular Diagnostic Reagent Product Portfolio
- 4.4.5 Roche Diagnostics Recent Developments
- 4.5 Siemens AG
- 4.5.1 Siemens AG Company Information
- 4.5.2 Siemens AG Business Overview
- 4.5.3 Siemens AG Molecular Diagnostic Reagent Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Siemens AG Molecular Diagnostic Reagent Product Portfolio
- 4.5.5 Siemens AG Recent Developments
- 4.6 Qiagen
- 4.6.1 Qiagen Company Information
- 4.6.2 Qiagen Business Overview
- 4.6.3 Qiagen Molecular Diagnostic Reagent Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Qiagen Molecular Diagnostic Reagent Product Portfolio
- 4.6.5 Qiagen Recent Developments
- 4.7 Illumina
- 4.7.1 Illumina Company Information
- 4.7.2 Illumina Business Overview
- 4.7.3 Illumina Molecular Diagnostic Reagent Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Illumina Molecular Diagnostic Reagent Product Portfolio
- 4.7.5 Illumina Recent Developments
- 4.8 Hologic
- 4.8.1 Hologic Company Information
- 4.8.2 Hologic Business Overview
- 4.8.3 Hologic Molecular Diagnostic Reagent Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Hologic Molecular Diagnostic Reagent Product Portfolio
- 4.8.5 Hologic Recent Developments
- 4.9 Grifols
- 4.9.1 Grifols Company Information
- 4.9.2 Grifols Business Overview
- 4.9.3 Grifols Molecular Diagnostic Reagent Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Grifols Molecular Diagnostic Reagent Product Portfolio
- 4.9.5 Grifols Recent Developments
- 4.10 Diasorin
- 4.10.1 Diasorin Company Information
- 4.10.2 Diasorin Business Overview
- 4.10.3 Diasorin Molecular Diagnostic Reagent Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Diasorin Molecular Diagnostic Reagent Product Portfolio
- 4.10.5 Diasorin Recent Developments
- 4.11 Danaher Corporation
- 4.11.1 Danaher Corporation Company Information
- 4.11.2 Danaher Corporation Business Overview
- 4.11.3 Danaher Corporation Molecular Diagnostic Reagent Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Danaher Corporation Molecular Diagnostic Reagent Product Portfolio
- 4.11.5 Danaher Corporation Recent Developments
- 4.12 DaAn Gene
- 4.12.1 DaAn Gene Company Information
- 4.12.2 DaAn Gene Business Overview
- 4.12.3 DaAn Gene Molecular Diagnostic Reagent Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 DaAn Gene Molecular Diagnostic Reagent Product Portfolio
- 4.12.5 DaAn Gene Recent Developments
- 4.13 Bio-Rad Laboratories
- 4.13.1 Bio-Rad Laboratories Company Information
- 4.13.2 Bio-Rad Laboratories Business Overview
- 4.13.3 Bio-Rad Laboratories Molecular Diagnostic Reagent Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Bio-Rad Laboratories Molecular Diagnostic Reagent Product Portfolio
- 4.13.5 Bio-Rad Laboratories Recent Developments
- 4.14 Biomérieux Sa
- 4.14.1 Biomérieux Sa Company Information
- 4.14.2 Biomérieux Sa Business Overview
- 4.14.3 Biomérieux Sa Molecular Diagnostic Reagent Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Biomérieux Sa Molecular Diagnostic Reagent Product Portfolio
- 4.14.5 Biomérieux Sa Recent Developments
- 4.15 Becton, Dickinson and Company
- 4.15.1 Becton, Dickinson and Company Company Information
- 4.15.2 Becton, Dickinson and Company Business Overview
- 4.15.3 Becton, Dickinson and Company Molecular Diagnostic Reagent Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Becton, Dickinson and Company Molecular Diagnostic Reagent Product Portfolio
- 4.15.5 Becton, Dickinson and Company Recent Developments
- 4.16 Agilent Technologies
- 4.16.1 Agilent Technologies Company Information
- 4.16.2 Agilent Technologies Business Overview
- 4.16.3 Agilent Technologies Molecular Diagnostic Reagent Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Agilent Technologies Molecular Diagnostic Reagent Product Portfolio
- 4.16.5 Agilent Technologies Recent Developments
5 Global Molecular Diagnostic Reagent Market Scenario by Region
- 5.1 Global Molecular Diagnostic Reagent Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Molecular Diagnostic Reagent Sales by Region: 2021-2032
- 5.2.1 Global Molecular Diagnostic Reagent Sales by Region: 2021-2026
- 5.2.2 Global Molecular Diagnostic Reagent Sales by Region: 2027-2032
- 5.3 Global Molecular Diagnostic Reagent Revenue by Region: 2021-2032
- 5.3.1 Global Molecular Diagnostic Reagent Revenue by Region: 2021-2026
- 5.3.2 Global Molecular Diagnostic Reagent Revenue by Region: 2027-2032
- 5.4 North America Molecular Diagnostic Reagent Market Facts & Figures by Country
- 5.4.1 North America Molecular Diagnostic Reagent Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Molecular Diagnostic Reagent Sales by Country (2021-2032)
- 5.4.3 North America Molecular Diagnostic Reagent Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Molecular Diagnostic Reagent Market Facts & Figures by Country
- 5.5.1 Europe Molecular Diagnostic Reagent Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Molecular Diagnostic Reagent Sales by Country (2021-2032)
- 5.5.3 Europe Molecular Diagnostic Reagent Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Molecular Diagnostic Reagent Market Facts & Figures by Country
- 5.6.1 Asia Pacific Molecular Diagnostic Reagent Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Molecular Diagnostic Reagent Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Molecular Diagnostic Reagent Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Molecular Diagnostic Reagent Market Facts & Figures by Country
- 5.7.1 South America Molecular Diagnostic Reagent Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Molecular Diagnostic Reagent Sales by Country (2021-2032)
- 5.7.3 South America Molecular Diagnostic Reagent Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Molecular Diagnostic Reagent Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Molecular Diagnostic Reagent Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Molecular Diagnostic Reagent Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Molecular Diagnostic Reagent Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Molecular Diagnostic Reagent Sales by Type (2021-2032)
- 6.1.1 Global Molecular Diagnostic Reagent Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Molecular Diagnostic Reagent Sales Market Share by Type (2021-2032)
- 6.2 Global Molecular Diagnostic Reagent Revenue by Type (2021-2032)
- 6.2.1 Global Molecular Diagnostic Reagent Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Molecular Diagnostic Reagent Revenue Market Share by Type (2021-2032)
- 6.3 Global Molecular Diagnostic Reagent Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Molecular Diagnostic Reagent Sales by Application (2021-2032)
- 7.1.1 Global Molecular Diagnostic Reagent Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Molecular Diagnostic Reagent Sales Market Share by Application (2021-2032)
- 7.2 Global Molecular Diagnostic Reagent Revenue by Application (2021-2032)
- 7.2.1 Global Molecular Diagnostic Reagent Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Molecular Diagnostic Reagent Revenue Market Share by Application (2021-2032)
- 7.3 Global Molecular Diagnostic Reagent Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Molecular Diagnostic Reagent Value Chain Analysis
- 8.1.1 Molecular Diagnostic Reagent Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Molecular Diagnostic Reagent Production Mode & Process
- 8.2 Molecular Diagnostic Reagent Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Molecular Diagnostic Reagent Distributors
- 8.2.3 Molecular Diagnostic Reagent Customers
9 Global Molecular Diagnostic Reagent Analyzing Market Dynamics
- 9.1 Molecular Diagnostic Reagent Industry Trends
- 9.2 Molecular Diagnostic Reagent Industry Drivers
- 9.3 Molecular Diagnostic Reagent Industry Opportunities and Challenges
- 9.4 Molecular Diagnostic Reagent Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst